ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 118 filers reported holding ANIKA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $129 | +108.1% | 5,112 | +87.9% | 0.00% | 0.0% |
Q4 2023 | $62 | -4.6% | 2,721 | -22.3% | 0.00% | 0.0% |
Q3 2023 | $65 | -29.3% | 3,500 | -1.5% | 0.00% | -25.0% |
Q2 2023 | $92 | -10.7% | 3,554 | -0.6% | 0.00% | 0.0% |
Q1 2023 | $103 | -2.8% | 3,575 | -0.3% | 0.00% | -20.0% |
Q4 2022 | $106 | -99.9% | 3,587 | -9.0% | 0.01% | +25.0% |
Q3 2022 | $94,000 | -5.1% | 3,941 | -11.6% | 0.00% | +33.3% |
Q2 2022 | $99,000 | -10.0% | 4,456 | +1.3% | 0.00% | 0.0% |
Q1 2022 | $110,000 | -39.2% | 4,399 | -12.9% | 0.00% | -25.0% |
Q4 2021 | $181,000 | -15.4% | 5,049 | +0.6% | 0.00% | -20.0% |
Q3 2021 | $214,000 | -5.7% | 5,020 | -4.2% | 0.01% | +25.0% |
Q2 2021 | $227,000 | -37.6% | 5,240 | -41.3% | 0.00% | -42.9% |
Q1 2021 | $364,000 | +111.6% | 8,921 | +134.5% | 0.01% | +75.0% |
Q4 2020 | $172,000 | +27.4% | 3,804 | 0.0% | 0.00% | +33.3% |
Q3 2020 | $135,000 | -6.2% | 3,804 | 0.0% | 0.00% | -25.0% |
Q2 2020 | $144,000 | – | 3,804 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Portolan Capital Management | 217,105 | $10,058,000 | 2.20% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 284,393 | $13,175,000 | 0.88% |
AMI ASSET MANAGEMENT CORP | 183,494 | $8,501,000 | 0.84% |
CAPITAL MANAGEMENT CORP /VA | 49,765 | $2,306,000 | 0.74% |
TFS CAPITAL LLC | 105,839 | $4,904,000 | 0.39% |
Baltimore-Washington Financial Advisors, Inc. | 24,390 | $1,130,000 | 0.35% |
OBERWEIS ASSET MANAGEMENT INC/ | 27,600 | $1,279,000 | 0.32% |
Stephens Investment Management Group LLC | 192,650 | $8,925,000 | 0.27% |
THOMPSON SIEGEL & WALMSLEY LLC | 263,622 | $12,214,000 | 0.24% |
DIKER MANAGEMENT LLC | 21,200 | $982,000 | 0.22% |